References

Australian Department of Health. Information for paramedics and ambulance first responders. 2020. https//www.health.gov.au/sites/default/files/documents/2020/02/coronavirus-covid-19-information-for-paramedics-and-ambulance-first-responders_0.pdf (accessed 25 June 2020)

Operations manual part A, section app B, flying staff instructions: operations with EC135 separation curtain. Revision 1. 2020;

Bornstein SR, Rubino F, Khunti K Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol.. 2020; 8:(6)546-550 https://doi.org/10.1016/S2213-8587(20)30152-2

UK air ambulance works with RAF during pandemic. 2020. https//tinyurl.com/ybfe7dfl (accessed 20 June 2020)

Centers for Disease Control and Prevention. Symptoms of coronavirus. 2020. https//tinyurl.com/sj3ssz2 (accessed 20 June 2020)

Cook TM, El-Boghdadly K, McGuire B, McNarry AF, Patel A, Higgs A. Consensus guidelines for managing the airway in patients with COVID-19: guidelines from the Difficult Airway Society, the Association of Anaesthetists the Intensive Care Society, the Faculty of Intensive Care Medicine and the Royal College of Anaesthetists. Anaesthesia. 2020; 75:(6)785-799 https://doi.org/10.1111/anae.15054

Li J, Wang X, Chen J, Zuo X, Zhang H, Deng A. COVID-19 infection may cause ketosis and ketoacidosis. Diabetes Obes Metab.. 2020; https://doi.org/10.1111/dom.14057

Norwegian Institute of Public Health. Aerosol generating procedures in health care, and COVID-19. 2020. https//www.fhi.no/globalassets/dokumenterfiler/rapporter/2020/aerosol-generating-procedures-in-health-care-and-covid19-rapport-2020.pdf (accessed 25 June 2020)

O'Neil CA, Li J, Leavey A Characterization of aerosols generated during patient care activities. Clin Infect Dis.. 2017; 65:(8)1335-1341 https://doi.org/10.1093/cid/cix535

Public Health England. COVID-19: guidance for ambulance trusts. 2020a. https//tinyurl.com/y78tz3gc (accessed 20 June 2020)

Public Health England. COVID-19: investigation and initial clinical management of possible cases. 2020b. https//tinyurl.com/w2fnd7z (accessed 20 June 2020)

Public Health England. COVID-19: infection prevention and control (IPC). Transmission characteristics and principles of infection prevention and control: guidance. 2020c. https//tinyurl.com/y9kqc92z (accessed 20 June 2020)

Public Health England. 8.1. Aerosol generating procedures. 2020d. https//tinyurl.com/yd9x8a2m (accessed 20 June 2020)

Resuscitation Council (UK). Resuscitation Council UK statement on COVID-19 in relation to CPR and resuscitation in acute hospital settings. 2020a. https//tinyurl.com/ww29mch (accessed 20 June 2020)

Resuscitation Council (UK). RCUK Statement on PHE PPE guidance. 2020b. https//tinyurl.com/qn6wdqx (accessed 20 June 2020)

Royal College of Emergency Medicine. Pharmacological agents for procedural sedation and analgesia in the emergency department: best practice guideline. 2019. https//tinyurl.com/yxe7gvqn (accessed 20 June 2020)

Sohrabi C, Alsafi Z, O'Neill N World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). Int J Surg.. 2020; 76:71-76 https://doi.org/10.1016/j.ijsu.2020.02.034

Tang X, Wu C, Li X On the origin and continuing evolution of SARS-CoV-2. Natl Sci Rev.. 2020a; 7:(6)1012-1023 https://doi.org/10.1093/nsr/nwaa036

Tang JW, Petri Kalliomaki P, Varila TM, Waris M, Koskela H. Nebulisers as a potential source of airborne virus. J Infect.. 2020b; https://doi.org/10.1016/j.jinf.2020.05.025

Wong SH, Lui RN, Sung JJ. Covid-19 and the digestive system. J Gastroenterol Hepatol.. 2020; 35:(5)744-748 https://doi.org/10.1111/jgh.15047

World Health Organization, Unicef. Water, sanitation, hygiene, and waste management for the COVID-19 virus: interim guidance. 2020a. https//tinyurl.com/ybj2zre5 (accessed 20 June 2020)

World Health Organization. Infection prevention and control during health care when COVID-19 is suspected. 2020. https//www.who.int/publications/i/item/10665-331495 (accessed 20 June 2020)

Wölfel R, Corman VM, Guggemos W Virological assessment of hospitalized patients with COVID-2019. Nature. 2020; 581:(7809)465-469 https://doi.org/10.1038/s41586-020-2196-x

Yan CH, Faraji F, Prajapati DP, Boone CE, DeConde AS. Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms. Int Forum Allergy Rhinol.. 2020; https://doi.org/10.1002/alr.22579

Yorkshire Air Ambulance COVID 19 update 30/03/2020. 2020. https//tinyurl.com/y8kc5asd (accessed 20 June 2020)

Zheng S, Fan J, Yu F Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. BMJ.. 2020; 369 https://doi.org/10.1136/bmj.m1443

COVID-19: experiences of roadside logistics from a UK air ambulance service

02 July 2020
Volume 12 · Issue 7

Abstract

The COVID-19 pandemic is so widespread that any patient in the prehospital environment is considered a significant transmission risk. UK charity air ambulances are affected by challenges regarding air equipment decontamination, staff redeployment and acquisition of personal protective equipment. This has led services to change their mode of operation and contribute to other areas of healthcare that have sprung up in response to the pandemic. Implementing adapted processes and assuming a clear clinical approach can help prevent transmission and uphold service integrity.

COVID-19 is short for coronavirus disease 2019, which causes severe acute respiratory syndrome (SARS). The virus found to cause the illness is structurally similar to other SARS-causing coronaviruses, and was therefore named SARS-CoV-2 (Tang et al, 2020a).

The viral pandemic originated in China's Wuhan region at the end of 2019 (Sohrabi et al, 2020) and was declared a global health emergency by the World Health Organization (WHO) (2020) a month later. It was another 3 weeks before Public Health England (PHE) (2020a) released its first novel coronavirus-specific guidance for ambulance services; this has since been adapted numerous times, as knowledge increases and evidence emerges.

The outbreak has been established as having such a sustained spread in the UK that any patient encounter (within 2 metres) requires a degree of personal protective equipment (PPE) (PHE, 2020a). High demand and low supply of PPE, along with helicopter emergency medical services (HEMS) staff being redeployed to frontline ambulance services have left some air ambulance services with a lack of PPE and some having to ground helicopters (Yorkshire Air Ambulance, 2020).

Hampshire and Isle of Wight Air Ambulance (HIOWAA) holds central professional cooperatives with Babcock, which supplies aviation services, and University Hospital Southampton (UHS), which employs and governs HEMS paramedics. The HEMS doctors are consultants who hold substantive posts at various hospitals in Hampshire. HIOWAA has been able to continue operations throughout the pandemic and expand its efforts into other areas in anticipation of a regional or national caseload surge.

Paramedics have been redeployed to the UHS emergency department to work alongside nursing and medical staff. HIOWAA is one of few charity air ambulances supporting a Royal Air Force COVID-19 task group in long-distance national aeromedical retrieval (Bullock, 2020). These changes have been facilitated by reducing assets from two double-staffed vehicles per day (one helicopter and one response car) to a single helicopter response with three medical crew members. This ensures that the service maintains HEMS operations, and provides a ‘clean’ crew member to manage logistics and communications.

Transmission and protection

Symptoms of COVID-19 were initially described as being flu-like, with a persistent cough and shortness of breath as leading features. A loss of smell or taste has also since been identified as a hallmark symptom, particularly following a fever (Centers for Disease Control and Prevention (CDC), 2020; PHE, 2020b; Yan et al, 2020). A correlation has also been found between COVID-19 and ketoacidosis in people with diabetes, which should trigger a clinician's suspicion if encountered (Bornstein et al, 2020; Li et al, 2020).

Gastrointestinal symptoms and faecal transmission have been thought to be significant (Wong et al, 2020), and PHE (2020c) advises that any patient-generated liquid with the exception of sweat should be treated as potentially infectious. WHO and Unicef (2020) dismissed the risk of transmission through faecal matter as low, stating it is unlikely despite the evidence demonstrating otherwise. Zheng et al (2020) established high viral loads in stool only 2 days before guidance from WHO and Unicef were published. It is therefore reasonable to maintain caution around any bodily secretion and excretion.

Droplets from the respiratory tract are the main concern for transmission, and are also of most relevance to prehospital teams. These droplets can infect through primary exposure and secondarily via contact with surfaces (PHE, 2020c). As the lower airways have been shown to hold a significant viral load over the course of the disease as well as after the end of symptoms, there is a risk of producing airborne particles when performing aerosol-generating procedures (AGPs) (Wölfel et al, 2020). AGPs are defined by the New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG) an expert committee of the Department of Health (DH), which informs the guidance produced by PHE.

Aerosol-generating procedures

Currently, the list of aerosol-generating procedures includes:

  • Intubation, extubation and related procedures, for example manual ventilation and open suctioning of the respiratory tract (including the upper respiratory tract)
  • Tracheotomy or tracheostomy procedures (insertion, open suctioning or removal)
  • Bronchoscopy and upper ear, nose and throat airway procedures that involve suctioning
  • Upper gastrointestinal endoscopy where there is open suctioning of the upper respiratory tract
  • Surgery and post-mortem procedures involving high-speed devices
  • Some dental procedures (for example high-speed drilling)
  • Non-invasive ventilation; bi-level positive airway pressure ventilation and continuous positive airway pressure ventilation
  • High-frequency oscillatory ventilation
  • Induction of sputum
  • High-flow nasal oxygen (PHE, 2020d: 8.1).
  • Administration of nebulised medication has been advised against by the Australian Department of Health (2020), the CDC (2020) and the Norwegian Institute of Public Health (2020). However, nebulisation has yet to be recognised as an AGP in UK guidance, although its potential to spread organic particles from a patient receiving treatment has been demonstrated (O'Neil et al, 2017; Tang, 2020b). As many nebuliser masks do not incorporate a valve or filter, there is a theoretical risk of droplets from exhalation or coughing in particular being propelled into the ‘acorn’, and subsequently aerosolised and spread through the environment.

    Cardiopulmonary resuscitation

    Interaction with any patient (within 2 metres) requires the use of level 2 PPE (Figure 1) as a minimum, and any AGP must only be undertaken while wearing level 3 (Figures 3 and 5; Table 1).

    Figure 1. HIOWAA attending a traffic accident in level 2 PPE; no aerosol-generating procedures were carried out. Not the incident in the case study
    Figure 2. Helimed 56 air ambulance
    Figure 3. Simulating an AGP wearing level 3 PPE
    Figure 4. HIOWAA staff giving a patient a blood transfusion on the way to hospital (same case as that shown in Figure 1)
    Figure 5. HIOWAA team after one of the first intubations done in level 3 PPE

    Personal protective equipment (PPE)
    Level 2 Level 3
    Disposable gloves Disposable gloves
    Disposable apron Fluid-repellent coveralls/long-sleeved apron/gown
    Fluid-repellent surgical mask FFP3* or powered respirator hood
    Eye protection (if risk of splashing) Eye protection
    * Where an FFP3 mask with a non-shrouded valve is worn, it should be accompanied by a full-face visor Source: adapted from PHE (2020a)

    Given this, cardiopulmonary resuscitation (CPR) has become a contested topic. Guidance from the Resuscitation Council (UK) has treated chest compressions as an AGP since the beginning of April (2020a). This position was asserted in a statement published on 20 April, which challenged PHE's decision to not identify chest compressions as aerosol-generating (Resuscitation Council (UK) (RCUK), 2020b). Presumably in response to this, PHE updated its guidance 4 days later, reiterating that chest compressions were a non-AGP (PHE, 2020d).

    HIOWAA adopted AGP guidance from both PHE and RCUK and extended this to include chest decompression by both needle and scalpel technique, as well as procedural sedation. There is no published evidence to support these being aerosol-generating, but they were included by rationale. Chest decompression is performed to release pressure, which can be caused by a pathologic conduit between the lung and chest cavity, as in a closed pneumothorax. The procedure itself can create an iatrogenic passageway using either technique. Procedural sedation is not aerosolising, but adverse effects of oversedation or ketamine-induced laryngospasm would trigger airway instrumentation (Royal College of Emergency Medicine, 2019).

    Preventing transmission

    Many of the skills added by HEMS teams are defined as aerosol-generating, requiring level 3 PPE. HIOWAA uses a set-up of FFP3 face masks, surgical caps, full face visors, generic high-density polyethylene fibre suits and double gloves, with one pair being high-hilted. As an added measure, a paramedic crew member will avoid getting within 2 metres of the patient and remain with the equipment, preparing the drugs or technical equipment required.

    Most materials used by HIOWAA are similar to those used by the local ambulance service, which makes it easier for the HEMS team to limit exposure of its own equipment, while still adding advanced drugs, video laryngoscopy and surgical airway equipment, surgical skills and prehospital blood transfusion (Figure 4).

    The revised HIOWAA standard operating procedure for prehospital emergency anaesthesia (PHEA) has been amended to fit with new guidance. Airway management is designated exclusively to the most experienced airway interventionist in the team, and should be done using video laryngoscopy (Cook et al, 2020). To limit the spread of aerosols, ventilations are withheld until the circuit has been closed by cuff inflation and a micro-particle filter and a closed in-line suction circuit are used.

    No patient by air unless confirmed negative

    At the time of writing, no patients are transported by air unless they have been confirmed to be negative for COVID-19 because of difficulties in decontaminating aviation instruments. Babcock (2020) has taken steps to mitigate this by the installing a separation curtain, and PHE (2020a) has changed its guidance to allow for air transfer, which may precipitate a shift towards operations similar to before the pandemic.

    Most of air ambulance Helimed 56's (Figure 2) local primary response area has excellent road infrastructure, and the critical care team's modus operandi was to ‘deploy by air, deliver by road’ in the majority of cases, even before the pandemic. It seems appropriate to limit the risk of aircraft contamination, especially as HIOWAA has only a single aircraft at its disposal.

    Case study: road traffic collision

    Helimed 56 (Figure 2) was called to a single-vehicle road traffic collision on a motorway. The air crew consisted of a doctor and two paramedics.

    On approach to land, the aircrew could see that the ambulance service and the hazardous area response team were in attendance. UK Helimed 56 was forced to land in an adjacent field as traffic was still moving on the opposite carriageway.

    After negotiating a tall motorway fence to gain access to the scene, the HEMS doctor donned a surgical face mask, gloves and an apron, and approached the crashed vehicle to liaise with the ambulance crew.

    The patient was medically trapped with a head injury, combative and agitated. In light of this and a decision by the prehospital critical care team to provide PHEA, one paramedic prepared a syringe of ketamine while the other laid out FFP3 face masks, surgical head caps, full-face visors, gauntlet gloves and high-density polyethylene fibre suits. The doctor and one of the paramedics donned the PPE before returning to the patient side to aid extrication.

    The third crew member established a cordon on the left-hand side of the ambulance where no patient-facing personnel would be allowed, and designated the rear of the ambulance for the anticipated aerosol-generating procedure (AGP).

    Equipment and drugs for PHEA and maintenance sedation were prepared in the clean zone on the left side of the ambulance and deposited into the ambulance from the side door, allowing contaminated crew members to retrieve this via the back of the ambulance.

    The patient was successfully intubated and connected to a closed circuit, and taken to the major trauma centre 15 minutes away by road. The ‘clean’ crew member travelled in the front of the ambulance, and provided a hospital pre-alert and dispensed drugs and equipment to the crew members travelling in the patient compartment through the bulkhead hatch.

    When Helimed 56 attends an incident, the lead clinician and the most suitable other crew member will don appropriate PPE. The third crew member will designate a clean area where they can work and, if possible, an area where AGPs are performed unless this must take place where the patient is situated. The role of the third crew member yields a high task load and it can help if there are uncontaminated health professionals who can work in the clean area. In any case, communication and logistics must be clear at all times to ensure the integrity of equipment and crew.

    The clean area should be upwind of any AGP, and it can be beneficial to use the ambulance as an intermediary space between a clean and a contaminated site when circumstances and vehicle design allows. In Figure 6, the third crew member established a cordon on the left-hand side of the ambulance where no patient-facing personnel would be allowed, and designated the rear of the ambulance for the anticipated AGP. A fire truck was parked on the right hand side of the ambulance, creating a natural canal for the patient to be transported into the AGP zone. The inside of the ambulance is treated as contaminated, and kit can delivered in from the side, where it becomes accessible to contaminated personnel from the rear of the vehicle. It is already typical for Helimed 56 to perform PHEA and surgical procedures on the ambulance stretcher at the back of the attending ambulance.

    Figure 6. Ambulance separating clean and contaminated areas

    This allows 360° access to the patient, a short distance to retrieve spares in case of equipment failure (other than that accounted for in preparation) and quick access to the inside of the ambulance to keep momentum towards definitive care. An added benefit is that the AGP is performed in a well-ventilated area, adhering to WHO (2020) recommendations. This also reduces contamination to contact surfaces once the patient and practitioners are inside the ambulance, as long as the circuit remains closed throughout.

    The front compartment of the ambulance remains clean throughout. To maintain this, the clean HEMS crew member will assist the driver in a safe doffing procedure developed by the HIOWAA clinical management team. The clean crew member can then keep equipment clean in the front cab, and prepare and pass any equipment required to the clinical team. At the end point after hospital handover, the safe doffing procedure is, again, adopted by the clinical team. As a rule, a minimal amount of non-consumable equipment requires decontamination, and can be decontaminated with disposable viricidal wipes, making the HEMS team ready within minutes.

    In summary

    COVID-19 is caused by SARS-CoV-2, and is now assumed to be widespread in the populace. It poses a risk to healthcare personnel, particularly through transmission by droplets and subsequent contact with affected surfaces.

    The novel coronavirus infects the respiratory tract throughout the course of illness, causing procedures and instrumentation that convert droplets to aerosols to pose particular high risk. These require people to be more mindful around safe distancing and the use of PPE. Constantly changing and unpredictable environments are a hallmark of prehospital practice, and critical care teams operating in these conditions must remain adaptive and resilient.

    Equally, operation strategies are changing rapidly as new knowledge around COVID-19 emerges. Readily available processes are necessary to keep healthcare providers and patients safe, and clear communication and understanding of roles can enforce this at the roadside.

    Although the case study presented herein is not readily generalisable, many of its underpinning principles are.

    Key points

  • Droplets put under pressure can aerosolise into microparticulates and spread through air
  • Coronavirus is spread in several ways; transmission by droplets from the respiratory tract is of particular concern in the prehospital environment
  • CPR and nebuliser administration are not defined as aerosol-generating in guidance, but contested by some research and best practice guidance
  • Conscious and correct use of the right PPE is important to preserve responder safety
  • Clear communication and scene command, including designating appropriate hot, warm and cold zones can help limit contamination of equipment
  • Designating a person to stay clean and handle uncontaminated equipment facilitates increased responder safety, preservation of equipment and reduced turnaround times
  • Using and working in PPE is best supported by a solid response framework and rehearsed procedures
  • CPD Reflection Questions

  • Which procedures do you feel put you at highest risk of COVID-19?
  • How do you work within a team to preserve the safety of yourself and others?
  • What steps do you take to limit transmission risk between patients?